Hyaluronan fragments: An information-rich system

European Journal of Cell Biology

Volumn 85, Issue 8, 2006, Pages 699-715

  Stern, Robert ^a   Asari, Akira A ^b   Sugahara, Kazuki N ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Glycoscience Laboratories ^*  (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Extracellular matrix; Glycosaminoglycans; Hyaluronan; Hyaluronidase; Oligosaccharides

Indexed keywords

CELL SURFACE RECEPTOR; DISACCHARIDE; GLUCURONIC ACID; GLYCOSAMINOGLYCAN; HEAT SHOCK PROTEIN; HYALURONIC ACID; LIGAND; N ACETYLGLUCOSAMINE; POLYMER; POLYSACCHARIDE; SYNTHETASE;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CATABOLISM; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; DEGRADATION; EMBRYO DEVELOPMENT; ENZYME MECHANISM; EPITHELIUM; EXTRACELLULAR MATRIX; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; INFLAMMATION; MAMMAL; MOLECULAR SIZE; NONHUMAN; OVULATION; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TURNOVER TIME; WOUND HEALING;

MAMMALIA;

EID: 33746040501     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2006.05.009     Document Type: Article

References (178)

1. Agren U.M., Tammi R.H., and Tammi M.I. Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radical Biol. Med. 23 (1997) 996-1001
2. Aoki K., Matsumoto S., Hirayama Y., Wada T., Ozeki Y., Niki M., Domenech P., Umemori K., Yamamoto S., Mineda A., Matsumoto M., and Kobayashi K. Extracellular mycobacterial DNA-binding protein 1 participates in mycobacterium-lung epithelial cell interaction through hyaluronic acid. J. Biol. Chem. 279 (2004) 39798-39806
3. Back S.A., Tuohy T.M., Chen H., Wallingford N., Craig A., Struve J., Luo N.L., Banine F., Liu Y., Chang A., Trapp B.D., Bebo Jr. B.F., Rao M.S., and Sherman L.S. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 11 (2005) 966-972
4. Balazs E.A. Viscoeleastic properties of hyaluronan and its therapeutic use. In: Garg H.G., and Hales C.A. (Eds). Chemistry and Biology of Hyaluronan (2004), Elsevier Press, Amsterdam 415-455
5. Balazs E.A., Laurent T.C., and Jeanloz R.W. Nomenclature of hyaluronic acid. Biochem. J. 235 (1986) 903
6. Banerjee S.D., and Toole B.P. Hyaluronan-binding protein in endothelial cell morphogenesis. J. Cell Biol. 119 (1992) 643-652
7. Banerji S., Ni J., Wang S.X., Clasper S., Su J., Tammi R., Jones M., and Jackson D.G. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 (1999) 789-801
8. Beck-Schimmer B., Oertli B., Pasch T., and Wuthrich R.P. Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J. Am. Soc. Nephrol. 9 (1998) 2283-2290
9. Berg S., Brodin B., Hesselvik F., Laurent T.C., and Maller R. Elevated levels of plasma hyaluronan in septicaemia. Scand. J. Clin. Lab. Invest. 48 (1988) 727-732
10. Bertrand P., and Delpech B. Interaction of hyaluronectin with hyaluronic acid oligosaccharides. J. Neurochem. 45 (1985) 434-439
11. Bono P., Cordero E., Johnson K., Borowsky M., Ramesh V., Jacks T., and Hynes R.O. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin. Exp. Cell Res. 308 (2005) 177-187
12. Bourguignon L.Y., Singleton P.A., Diedrich F., Stern R., and Gilad E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J. Biol. Chem. 279 (2004) 26991-27007
13. Bourguignon L.Y.W., Gilad E., Rothman K., and Peyrollier K. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling leading to actin binding, Elk/estrogen receptor transcriptional activation and ovarian cancer progression. J. Biol. Chem. 280 (2005) 11961-11972
14. Bratanich A., and Blanchetot A. A gene similar to the human hyaluronan-mediated motility receptor (RHAMM) gene is upregulated during porcine circovirus type 2 infection. Virus Genes 32 (2006) 145-152
15. Burd D.A. Hyaluronan and scarring. In: Garg H.G., and Hales C.A. (Eds). Chemistry and Biology of Hyaluronan (2004), Elsevier Press, Amsterdam 367-394
16. Burd D.A., Siebert J.W., Ehrlich H.P., and Garg H.G. Human skin and post-burn scar hyaluronan: demonstration of the association with collagen and other proteins. Matrix 9 (1989) 322-327
17. Camaioni A., Hascall V.C., Yanagishita M., and Salustri A. Effects of exogenous hyaluronic acid and serum on matrix organization and stability in the mouse cumulus cell-oocyte complex. J. Biol. Chem. 268 (1993) 20473-20481
18. Chai W., Beeson J.G., Kogelberg H., Brown G.V., and Lawson A.M. Inhibition of adhesion of Plasmodium falciparum-infected erythrocytes by structurally defined hyaluronic acid dodecasaccharides. Infect. Immun. 69 (2001) 420-425
19. Cheung W.F., Cruz T.F., and Turley E.A. Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochem. Soc. Trans. 27 (1999) 135-142
20. Cowman M.K., and Matsuoka S. Experimental approaches to hyaluronan structure. Carbohydr. Res. 340 (2005) 791-809
21. Culty M., Nguyen H.A., and Underhill C.B. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116 (1992) 1055-1062
22. Dahl L., Hopwood J.J., Laurent U.B., Lilja K., and Tengblad A. The concentration of hyaluronate in amniotic fluid. Biochem. Med. 30 (1983) 280-283
23. Day A.J., and de la Motte C.A. Hyaluronan cross-linking: a protective mechanism in inflammation?. Trends Immunol. 26 (2005) 637-643
24. Day A.J., and Prestwich G.D. Hyaluronan-binding proteins: tying up the giant. J. Biol. Chem. 277 (2002) 4585-4588
25. DeAngelis P.L. Hyaluronan synthases: fascinating glycosyltransferases from vertebrates, bacterial pathogens, and algal viruses. Cell. Mol. Life Sci. 56 (1999) 670-682
26. DeAngelis P.L. Molecular directionality of polysaccharide polymerization by the Pasteurella multocida hyaluronan synthase. J. Biol. Chem. 274 (1999) 26557-26562
27. Deb T.B., and Datta K. Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2. J. Biol. Chem. 271 (1996) 2206-2212
28. Deb T.B., Majumdar M., Bharadwaj A., Jha B.K., and Datta K. In: Kennedy J.F., Philips G.O., William P.A., and Hascall V.C. (Eds). Hyaluronan: Chemical, Biochemical and Biological Aspects vol. 1 (2002), Woodhead Publishing Ltd., Cambridge, UK 365-372
29. Decker M., Chiu E.S., Dollbaum C., Moiin A., Hall J., Spendlove R., Longaker M.T., and Stern R. Hyaluronic acid-stimulating activity in sera from the bovine fetus and from breast cancer patients. Cancer Res. 49 (1989) 3499-3505
30. Deed R., Rooney P., Kumar P., Norton J.D., Smith J., Freemont A.J., and Kumar S. Early response gene signaling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int. J. Cancer 71 (1997) 251-256
31. Deguine V., Menasche M., Ferrari P., Fraisse L., Pouliquen Y., and Robert L. Free radical depolymerization of hyaluronan by Maillard reaction products: role in liquefaction of aging vitreous. Int. J. Biol. Macromol. 22 (1998) 17-22
32. de la Motte C.A., Hascall V.C., Drazba J., Bandyopadhyay S.K., and Strong S.A. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am. J. Pathol. 163 (2003) 121-133
33. Delmage J.M., Powars D.R., Jaynes P.K., and Allerton S.E. The selective suppression of immunogenicity by hyaluronic acid. Ann. Clin. Lab. Sci. 16 (1986) 303-310
34. Evanko S.P., and Wight T.N. Intracellular localization of hyaluronan in proliferating cells. J. Histochem. Cytochem. 47 (1999) 1331-1342
35. Evanko S.P., Angello J.C., and Wight T.N. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1004-1013
36. Evanko S.P., Parks W.T., and Wight T.N. Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle. J. Histochem. Cytochem. 52 (2004) 1525-1535
37. Falkowski M., Schledzewski K., Hansen B., and Goerdt S. Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces. Histochem. Cell Biol. 120 (2003) 361-369
38. Feinberg R.N., and Beebe D.C. Hyaluronate in vasculogenesis. Science 220 (1983) 1177-1179
39. Fieber C., Baumann P., Vallon R., Termeer C., Simon J.C., Hofmann M., Angel P., Herrlich P., and Sleeman J.P. Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J. Cell Sci. 117 (2004) 359-367
40. Filion M.C., and Phillips N.C. Pro-inflammatory activity of contaminating DNA in hyaluronic acid preparations. J. Pharm. Pharmacol. 53 (2001) 555-561
41. Fitzgerald K.A., Bowie A.G., Skeffington B.S., and O'Neill L.A. Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells. J. Immunol. 164 (2000) 2053-2063
42. Forrester J.V., and Balazs E.A. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40 (1980) 435-446
43. Fraser J.R., Laurent T.C., and Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 242 (1997) 27-33
44. Frost S.J., and Weigel P.H. Binding of hyaluronic acid to mammalian fibrinogens. Biochim. Biophys. Acta 1034 (1990) 39-45
45. Fujii K., Fujii Y., Hubscher S., and Tanaka Y. CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells. J. Immunol. 167 (2001) 1198-1203
46. Fujisaki T., Tanaka Y., Fujii K., Mine S., Saito K., Yamada S., Yamashita U., Irimura T., and Eto S. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res. 59 (1999) 4427-4434
47. Fujita Y., Kitagawa M., Nakamura S., Azuma K., Ishii G., Higashi M., Kishi H., Hiwasa T., Koda K., Nakajima N., and Harigaya K. CD44 signaling through focal adhesion kinase and its anti-apoptotic effect. FEBS Lett. 528 (2002) 101-108
48. Ghatak S., Misra S., and Toole B.P. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J. Biol. Chem. 277 (2002) 38013-38020
49. Ghatak S., Misra S., and Toole B.P. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J. Biol. Chem. 280 (2005) 8875-8883
50. Ghosh P., and Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?. Semin. Arthritis Rheum. 32 (2002) 10-37
51. Grammatikakis N., Grammatikakis A., Yoneda M., Yu Q., Banerjee S.D., and Toole B.P. A novel glycosaminoglycan-binding protein is the vertebrate homologue of the cell cycle control protein, Cdc37. J. Biol. Chem. 270 (1995) 16198-16205
52. Granger H.J., Laine G.A., Barnes G.E., and Lewis R.E. Dynamics and control of transmicrovascular fluid exchange. In: Staub N.C., and Taylor A.E. (Eds). Edema (1984), Raven Press, New York 189-228
53. Guo M.M., and Hildreth J.E. HIV acquires functional adhesion receptors from host cells. AIDS Res. Hum. Retroviruses 11 (1995) 1007-1013
54. Hamaguchi M., Yoshida Y., Ohnuki Y., Miyauchi S., Spicer A.P., McDonald J.A., and Kimata K. Three isoforms of mammalian hylauronan synthases have distinct enzymatic properties. J. Biol. Chem. 274 (1999) 25085-25092
55. Hardingham T.E., and Muir H. Binding of oligosaccharides of hyaluronic acid to proteoglycans. Biochem. J. 135 (1973) 905-908
56. Hascall V.C., and Heinegård D. Aggregation of cartilage proteoglycans. II. Oligosaccharide competitors of the proteoglycan-hyaluronic acid interaction. J. Biol. Chem. 249 (1974) 4242-4249
57. Hascall V.C., Majors A.K., De La Motte C.A., Evanko S.P., Wang A., Drazba J.A., Strong S.A., and Wight T.N. Intracellular hyaluronan: a new frontier for inflammation?. Biochim. Biophys. Acta 1673 (2004) 3-12
58. Hedman K., Kurkinen M., Alitalo K., Vaheri A., Johansson S., and Höök M. Isolation of the pericellular matrix of human fibroblast cultures. J. Cell Biol. 81 (1979) 83-89
59. Hodge-Dufour J., Noble P.W., Horton M.R., Bao C., Wysoka M., Burdick M.D., Strieter R.M., Trinchieri G., and Pure E. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J. Immunol. 159 (1997) 2492-2500
60. Horton M.R., McKee C.M., Bao C., Liao F., Farber J.M., Hodge-DuFour J., Pure E., Oliver B.L., Wright T.M., and Noble P.W. Hyaluronan fragments synergize with interferon-γ to induce the C-X-C chemokines Mig and interferon-inducible protein-10 in mouse macrophages. J. Biol. Chem. 273 (1998) 35088-35094
61. Horton M.R., Olman M.A., and Noble P.W. Hyaluronan fragments induce plasminogen activator inhibitor-1 and inhibit urokinase activity in mouse alveolar macrophages: a potential mechanism for impaired fibrinolytic activity in acute lung injury. Chest 116 (1999) 17S
62. Horton M.R., Shapiro S., Bao C., Lowenstein C.J., and Noble P.W. Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J. Immunol. 162 (1999) 4171-4176
63. Horton M.R., Olman M.A., Bao C., White K.E., Choi A.M., Chin B.Y., Noble P.W., and Lowenstein C.J. Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 279 (2000) L707-L715
64. Hu Y., Crary J.J., Henderson M.B., and Thacker K. Highly purified hyaluronan is non-inflammatory across a broad range of molecular weights. In: Balazs E.A., and Hascall V.C. (Eds). Hyaluronan: Structure, Metabolism, Biological Activities, Therapeutic Applications vol. 1 (2005), Matrix Biology Institute Press, Edgewater, NJ 17-27
65. Iacob S., and Knudson C.B. Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes. Int. J. Biochem. Cell Biol. 38 (2006) 123-133
66. Itano N., and Kimata K. Molecular cloning of human hyaluronan synthase. Biochem. Biophys. Res. Commun. 222 (1996) 816-820
67. Itano N., and Kimata K. Mammalian hyaluronan synthases. IUBMB Life 54 (2002) 195-199
68. Itano N., Sawai T., Yoshida M., Lenas P., Yamada Y., Imagawa M., Shinomura T., Hamaguchi M., Yoshida Y., Ohnuki Y., Miyauchi S., Spicer A.P., McDonald J.A., and Kimata K. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem. 274 (1999) 25085-25092
69. Itano N., Sawai T., Atsumi F., Miyaishi O., Taniguchi S., Kannagi R., Hamaguchi M., and Kimata K. Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J. Biol. Chem. 279 (2004) 18679-18687
70. Jedrzejas M.J., and Stern R. Structure of vertebrate hyaluronidases and their unique mechanism of hydrolysis. Proteins 61 (2005) 227-238
71. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G.D., Mascarenhas M.M., Garg H.G., Quinn D.A., Homer R.J., Goldstein D.R., Bucala R., Lee P.J., Medzhitov R., and Noble P.W. Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat. Med. 11 (2005) 1173-1179
72. Jing W., and DeAngelis P.L. Synchronized chemoenzymatic synthesis of monodisperse hyaluronan polymers. J. Biol. Chem. 279 (2004) 42345-42349
73. Kahmann J.D., O'Brien R., Werner J.M., Heinegard D., Ladbury J.E., Campbell I.D., and Day A.J. Localization and characterization of the hyaluronan-binding site on the link module from human TSG-6. Struct. Fold. Des. 8 (2000) 763-774
74. Kennedy C.I., Diegelmann R.F., Haynes J.H., and Yager D.R. Proinflammatory cytokines differentially regulate hyaluronan synthase isoforms in fetal and adult fibroblasts. J. Pediatr. Surg. 35 (2000) 874-879
75. Kimura J.H., Hardingham T.E., Hascall V.C., and Solursh M. Biosynthesis of proteoglycans and their assembly into aggregates in cultures of chondrocytes from the Swarm rat chondrosarcoma. J. Biol. Chem. 254 (1979) 2600-2609
76. Kinoshita M., and Kakehi K. Analysis of the interaction between hyaluronan and hyaluronan binding proteins by capillary affinity electrophoresis: significance of hyaluronan molecular size on binding reaction. J. Chromatogr. B 816 (2005) 289-295
77. Knudson C.B. Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J. Cell Biol. 120 (1993) 825-834
78. Knudson W., and Knudson C.B. Assembly of a chondrocyte-like pericellular matrix on non-chondrogenic cells. Role of the cell surface hyaluronan receptors in the assembly of a pericellular matrix. J. Cell Sci. 99 (1991) 227-235
79. Knudson C.B., and Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 7 (1993) 1233-1241
80. Knudson C.B., and Knudson W. Hyaluronan and CD44: modulators of chondrocyte metabolism. Clin. Orthop. Relat. Res. 427 Suppl. (2004) S152-S162
81. Knudson, W., Knudson, C.B., 2004b. The hyaluronan receptor CD44, an update. http://www.glycoforum.gp.jp/science/hyaluronan/HA10a/HA10a.html.
82. Knudson W., Aguiar D.J., Hua Q., and Knudson C.B. CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp. Cell Res. 228 (1996) 216-228
83. Knudson W., Casey B., Nishida Y., Eger W., Kuettner K.E., and Knudson C.B. Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrocytic chondrolysis. Arthritis Rheum. 43 (2000) 1165-1174
84. Kohda D., Morton C.J., Parkar A.A., Hatanaka H., Inagaki F.M., Campbell I.D., and Day A.J. Solution structure of the link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 86 (1996) 767-775
85. Kujawa M.J., and Caplan A.I. Hyaluronic acid bonded to cell-culture surfaces stimulates chondrogenesis in stage 24 limb mesenchyme cell cultures. Dev. Biol. 114 (1986) 504-518
86. Kujawa M.J., Carrino D.A., and Caplan A.I. Substrate-bonded hyaluronic acid exhibits a size-dependent stimulation of chondrogenic differentiation of stage 24 limb mesenchymal cells in culture. Dev. Biol. 114 (1986) 519-528
87. Kujawa M.J., Pechak D.G., Fiszman M.Y., and Caplan A.I. Hyaluronic acid bonded to cell culture surfaces inhibits the program of myogenesis. Dev. Biol. 113 (1986) 10-16
88. Kumar S., West D.C., Ponting J.M., and Gattamaneni H.R. Sera of children with renal tumours contain low-molecular-mass hyaluronic acid. Int. J. Cancer 44 (1989) 445-448
89. Lara-Pezzi E., Serrador J.M., Montoya M.C., Zamora D., Yanez-Mo M., Carretero M., Furthmayr H., Sanchez-Madrid F., and Lopez-Cabrera M. The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis. Hepatology 33 (2001) 1270-1281
90. Laurent T.C., and Fraser J.R. Hyaluronan. FASEB J. 6 (1992) 2397-2404
91. Lee H.G., and Cowman M.K. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal. Biochem. 219 (1994) 278-287
92. Lee J.Y., and Spicer A.P. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell Biol. 12 (2000) 581-586
93. Lepperdinger G., Strobl B., and Kreil G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J. Biol. Chem. 273 (1998) 22466-22470
94. Lepperdinger G., Mullegger J., and Kreil G. Hyal2-less active, but more versatile?. Matrix Biol. 20 (2001) 509-514
95. Lepperdinger G., Fehrer C., and Reitlinger S. Biodegradation of hyaluronan. In: Garg H.G., and Hales C.A. (Eds). Chemistry and Biology of Hyaluronan (2004), Elsevier Press, Amsterdam 71-82
96. Lesley J., Hascall V.C., Tammi M., and Hyman R. Hyaluronan binding by cell surface CD44. J. Biol. Chem. 275 (2000) 26967-26975
97. Locci P., Marinucci L., Lilli C., Martinese D., and Becchetti E. Transforming growth factor beta 1-hyaluronic acid interaction. Cell Tissue Res. 281 (1995) 317-324
98. Lokeshwar V.B., and Selzer M.G. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J. Biol. Chem. 275 (2000) 27641-27649
99. Lokeshwar V.B., Iida I., and Bourguignon L.Y.W. The cell adhesion molecule, GP116, is a new CD44 variant (ex14/v10) involved in hyaluronic acid binding and endothelial cell proliferation. J. Biol. Chem. 271 (1996) 23853-23864
100. Lokeshwar V.B., Oebek C., Soloway M.S., and Block N.L. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res. 57 (1997) 773-777
101. Lueke H.J., and Prehm P. Synthesis and shedding of hyaluronan from plasma membranes of human fibroblasts and metastatic and non-metastatic melanoma cells. Biochem. J. 343 (1999) 71-75
102. Lynn B.D., Li X., Cattini P.A., Turley E.A., and Nagy J.I. Identification of sequence, protein isoforms, and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain. J. Comp. Neurol. 439 (2001) 315-330
103. Mahoney D.J., Aplin R.T., Calabro A., Hascall V.C., and Day A.J. Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length. Glycobiology 11 (2001) 1025-1033
104. Markowitz A., Cifonelli J.A., and Dorfman A. The biosynthesis of hyaluronic acid by group A Streptococcus. J. Biol. Chem. 234 (1959) 2243-2247
105. Mascarenhas M.M., Day R.M., Ochoa C.D., Choi W.I., Yu L., Ouyang B., Garg H.G., Hales C.A., and Quinn D.A. Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. Am. J. Respir. Cell Mol. Biol. 30 (2004) 51-60
106. McBride W.H., and Bard J.B. Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. J. Exp. Med. 149 (1979) 507-515
107. McKee C.M., Penno M.B., Cowman M., Burdick M.D., Strieter R.M., Bao C., and Noble P.W. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98 (1996) 2403-2413
108. McKee C.M., Lowenstein C.J., Horton M.R., Wu J., Bao C., Chin B.Y., Choi A.M., and Noble P.W. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor NF-κB-dependent mechanism. J. Biol. Chem. 272 (1997) 8013-8018
109. Meyer K., and Palmer J.W. The polysaccharide of the vitreous humor. J. Biol. Chem. 107 (1934) 629-634
110. Misra S., Ghatak S., and Toole B.P. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J. Biol. Chem. 280 (2005) 20310-20315
111. Monfort J., Nacher M., Montell E., Vila J., Verges J., and Benito P. Chondroitin sulfate and hyaluronic acid (500-730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. Drugs Exp. Clin. Res. 31 (2005) 71-76
112. Morrison H., Sherman L.S., Legg J., Banine F., Isacke C., Haipek C.A., Gutmann D.H., Ponta H., and Herrlich P. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev. 15 (2001) 968-980
113. Moseley R., Waddington R.J., and Embery G. Degradation of glycosaminoglycans by reactive oxygen species derived from stimulated polymorphonuclear leukocytes. Biochim. Biophys. Acta 1362 (1997) 221-231
114. Mukhopadhyay D., Asari A., Rugg M.S., Day A.J., and Fulop C. Specificity of the tumor necrosis factor-induced protein 6-mediated heavy chain transfer from inter-alpha-trypsin inhibitor to hyaluronan: implications for the assembly of the cumulus extracellular matrix. J. Biol. Chem. 279 (2004) 11119-11128
115. Myint P., Deeble D.J., Beaumont P.C., Blake S.M., and Phillips G.O. The reactivity of various free radicals with hyaluronic acid: steady-state and pulse radiolysis studies. Biochim. Biophys. Acta 925 (1987) 194-202
116. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 21 (2002) 25-29
117. Noble P.W., Lake F.R., Henson P.M., and Riches D.W. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J. Clin. Invest. 91 (1993) 2368-2377
118. Noble P.W., McKee C.M., Cowman M., and Shin H.S. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha auto-regulatory loop in murine macrophages. J. Exp. Med. 183 (1996) 2373-2378
119. Ohkawara Y., Tamura G., Iwasaki T., Tanaka A., Kikuchi T., and Shirato K. Activation and transforming growth factor-beta production in eosinophils by hyaluronan. Am. J. Respir. Cell Mol. Biol. 23 (2000) 444-451
120. Ohno S., Im H.J., Knudson C.B., and Knudson W. Hyaluronan oligosaccharide-induced activation of transcription factors in bovine articular chondrocytes. Arthritis Rheum. 52 (2005) 800-809
121. Ohno S., Ohno-Nakahara M., Knudson C.B., and Knudson W. Induction of MMP-3 by hyaluronan oligosaccharides in temporomandibular joint chondrocytes. J. Dent. Res. 84 (2005) 1005-1009
122. Ohno-Nakahara M., Honda K., Tanimoto K., Tanaka N., Doi T., Suzuki A., Yoneno K., Nakatani Y., Ueki M., Ohno S., Knudson W., Knudson C.B., and Tanne K. Induction of CD44 and MMP expression by hyaluronidase treatment of articular chondrocytes. J. Biochem. (Tokyo) 135 (2004) 567-575
123. Okamoto I., Tsuiki H., Kenyon L.C., Godwin A.K., Emlet D.R., Holgado-Madruga M., Lanham I.S., Joynes C.J., Vo K.T., Guha A., Matsumoto M., Ushio Y., Saya H., and Wong A.J. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am. J. Pathol. 160 (2002) 441-447
124. Onarheim H., Missavage A.E., Gunther R.A., Kramer G.C., Reed R.K., and Laurent T.C. Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J. Surg. Res. 50 (1991) 259-265
125. Passi A., Sadeghi P., Kawamura H., Anand S., Sato N., White L.E., Hascall V.C., and Maytin E.V. Hyaluronan suppresses epidermal differentiation in organotypic cultures of rat keratinocytes. Exp. Cell Res. 296 (2004) 123-134
126. Politz O., Gratchev A., McCourt P.A., Schledzewski K., Guillot P., Johansson S., Svineng G., Franke P., Kannicht C., Kzhyshkowska J., Longati P., Velten F.W., Johansson S., and Goerdt S. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem. J. 362 (2002) 155-164
127. Ponta H., Sherman L., and Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 4 (2003) 33-45
128. Powell J.D., and Horton M.R. Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol. Res. 31 (2005) 207-218
129. Prehm P. Hyaluronate is synthesized at plasma membranes. Biochem. J. 220 (1984) 597-600
130. Prehm P., and Schumacher U. Inhibition of hyaluronan export from human fibroblasts by inhibitors of multidrug resistance transporters. Biochem. Pharmacol. 68 (2004) 1401-1410
131. Rai S.K., Duh F.M., Vigdorovich V., Danilkovitch-Miagkova A., Lerman I., and Miller A.D. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl. Acad. Sci. USA 98 (2001) 4443-4448
132. Rao C.M., Salotra P., and Datta K. Possible role of the 34-kilodalton hyaluronic acid-binding protein in visceral leishmaniasis. J. Parasitol. 85 (1999) 682-687
133. Recklies A.D., White C., Melching L., and Roughley P.J. Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem. J. 354 (2001) 17-24
134. Rockey D.C., Chung J.J., McKee C.M., and Noble P.W. Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. Hepatology 27 (1998) 86-92
135. Roden L., Campbell P., Fraser J.R., Laurent T.C., Pertoft H., and Thompson J.N. Enzymic pathways of hyaluronan catabolism. Ciba Found. Symp. 143 (1989) 60-76
136. Rooney P., Wang M., Kumar P., and Kumar S. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. J. Cell Sci. 105 (1993) 213-218
137. Rooney P., Kumar S., Ponting J., and Wang M. The role of hyaluronan in tumour neovascularization. Int. J. Cancer 60 (1995) 632-636
138. Saari H., Konttinen Y.T., Friman C., and Sorsa T. Differential effects of reactive oxygen species on native synovial fluid and purified human umbilical cord hyaluronate. Inflammation 17 (1993) 403-415
139. Sampson P.M., Rochester C.L., Freundlich B., and Elias J.A. Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. J. Clin. Invest. 90 (1992) 1492-1503
140. Sattar A., Rooney P., Kumar S., Pye D., West D.C., Scott I., and Ledger P. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J. Invest. Dermatol. 103 (1994) 576-579
141. Scott J.E., and Heatley F. Biological properties of hyaluronan in aqueous solution are controlled and sequestered by reversible tertiary structures, defined by NMR spectroscopy. Biomacromolecules 3 (2002) 547-553
142. Scott J.E., Heatley F., and Hull W.M. Secondary structure of hyaluronate in solution. A 1H-N.M.R. investigation at 300 and 500 MHz in [2H6]dimethyl sulphoxide solution. Biochem. J. 220 (1984) 197-205
143. Seyfried N.T., Blundell C.D., Day A.J., and Almond A. Preparation and application of biologically active fluorescent hyaluronan oligosaccharides. Glycobiology 15 (2005) 303-312
144. Seyfried N.T., McVey G.F., Almond A., Mahoney D.J., Dudhia J., and Day A.J. Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides. J. Biol. Chem. 280 (2005) 5435-5448
145. Slevin M., Krupinski J., Kumar S., and Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab. Invest. 78 (1998) 987-1003
146. Slevin M., Kumar S., and Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J. Biol. Chem. 277 (2002) 41046-41059
147. Soltes L., Stankovska M., Kogan G., Gemeiner P., and Stern R. Contribution of oxidative-reductive reactions to high molecular weight hyaluronan catabolism. Chem. Biodiv. 2 (2005) 1242-1245
148. Solursh M., Hardingham T.E., Hascall V.C., and Kimura J.H. Separate effects of exogenous hyaluronic acid on proteoglycan synthesis and deposition in pericellular matrix by cultured chick embryo limb chondrocytes. Dev. Biol. 75 (1980) 121-129
149. Stern R. Devising a pathway for hyaluronan catabolism: are we there yet?. Glycobiology 13 (2003) 105R-115R
150. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur. J. Cell Biol. 83 (2004) 317-325
151. Stern R., and Jedrzejas M.J. The hyaluronidases; their genomics, structures, and mechanisms of action. Chem. Rev. 106 (2006) 818-829
152. Sugahara K.N., Murai T., Nishinakamura H., Kawashima H., Saya H., and Miyasaka M. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J. Biol. Chem. 278 (2003) 32259-32265
153. Sugahara K.N., Hirata T., Murai T., and Miyasaka M. Hyaluronan oligosaccharides and tumor progression. Trends Glycosci. Glycotechnol. 16 (2004) 187-197
154. Sugahara K.N., Hirata T., Hayasaka H., Stern R., Murai T., and Miyasaka M. Tumor cells enhance their own CD44 cleavage and motility by generating hyaluronan fragments. J. Biol. Chem. 281 (2005) 5861-5868
155. Sugiyama Y., Shimada A., Sayo T., Sakai S., and Inoue S. Putative hyaluronan synthase mRNA are expressed in mouse skin and TGF-beta upregulates their expression in cultured human skin cells. J. Invest. Dermatol. 110 (1998) 116-121
156. Takahashi Y., Li L., Kamiryo M., Asteriou T., Moustakas A., Yamashita H., and Heldin P. Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner. J. Biol. Chem. 280 (2005) 24195-24204
157. Tammi R., MacCallum D., Hascall V.C., Pienimaki J.P., Hyttinen M., and Tammi M. Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides. J. Biol. Chem. 273 (1998) 28878-28888
158. Tammi R., Rilla K., Pienimaki J.P., MacCallum D.K., Hogg M., Luukkonen M., Hascall V.C., and Tammi M. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J. Biol. Chem. 276 (2001) 35111-35122
159. Taylor K.R., Trowbridge J.M., Rudisill J.A., Termeer C.C., Simon J.C., and Gallo R.L. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J. Biol. Chem. 279 (2004) 17079-17084
160. Teder P., Vandivier R.W., Jiang D., Liang J., Cohn L., Pure E., Henson P.M., and Noble P.W. Resolution of lung inflammation by CD44. Science 296 (2002) 155-158
161. Termeer C.C., Hennies J., Voith U., Ahrens T., Weiss J.M., Prehm P., and Simon J.C. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165 (2000) 1863-1870
162. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., and Simon J.C. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195 (2002) 99-111
163. Termeer C., Sleeman J.P., and Simon J.C. Hyaluronan-magic glue for the regulation of the immune response?. Trends Immunol. 24 (2003) 112-114
164. Toole B.P. Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol. 2 (1990) 839-844
165. Toole B.P. Proteoglycans and hyaluronan in morphogenesis and differentiation. In: Hay E.D. (Ed). Cell Biology of Extracellular Matrix (1991), Plenum Press, New York 61-92
166. Toole B.P. Hyaluronan is not just "goo". J. Clin. Invest. 106 (2000) 335-336
167. Uchiyama H., Dobashi Y., Ohkouchi K., and Nagasawa K. Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid. J. Biol. Chem. 265 (1990) 7753-7759
168. Wang S., and Bourguignon L.Y.W. Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 132 (2006) 19-24
169. Wang M.J., Jeng K.C., Kuo J.S., Chen H.L., Huang H.Y., Chen W.F., and Lin S.Z. c-Jun N-terminal kinase and, to a lesser extent, p38 mitogen-activated protein kinase regulate inducible nitric oxide synthase expression in hyaluronan fragments-stimulated BV-2 microglia. J. Neuroimmunol. 146 (2004) 50-62
170. Weigel P.H., Fuller G.M., and LeBoeuf R.D. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J. Theor. Biol. 119 (1986) 219-234
171. Weigel P.H., Hascall V.C., and Tammi M. Hyaluronan synthases. J. Biol. Chem. 272 (1997) 13997-14000
172. West D.C., and Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res. 183 (1989) 179-196
173. West D.C., Hampson I.N., Arnold F., and Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 228 (1985) 1324-1326
174. Xu H., Ito T., Tawada A., Maeda H., Yamanokuchi H., Isahara K., Yoshida K., Uchiyama Y., and Asari A. Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. J. Biol. Chem. 277 (2002) 17308-17314
175. Yoneda M., Suzuki S., and Kimata K. Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85-kDa protein. J. Biol. Chem. 265 (1990) 5247-5257
176. Zeng C., Toole B.P., Kinney S.D., Kuo J.W., and Stamenkovic I. Inhibition of tumor growth in vivo by hyaluronan oligomers. Int. J. Cancer 77 (1998) 396-401
177. Zhang S., Chang M.C., Zylka D., Turley S., Harrison R., and Turley E.A. The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J. Biol. Chem. 273 (1998) 11342-11348
178. Zhou B., Weigel J.A., Fauss L., and Weigel P.H. Identification of the hyaluronan receptor for endocytosis (HARE). J. Biol. Chem. 275 (2000) 37733-37741